2nd Edition of International Cancer and Precision Oncology Conference 2026

Overview

The 2nd Edition of International Cancer and Precision Oncology Conference (ICPOC 2026) (Hybrid Event) will take place from November 23-25, 2026, in Singapore and Online, bringing together a global network of oncologists, cancer researchers, clinicians, healthcare professionals, academic scientists, pharmaceutical experts, and industry leaders. Designed as a hybrid event, the conference provides a comprehensive platform for discussing recent developments and future directions in cancer research and personalized oncology. Cancer Conference aims to encourage scientific collaboration and multidisciplinary engagement by presenting innovative findings related to cancer diagnosis, treatment strateg...ies, prevention methods, and translational medicine. Participants will explore advancements in molecular oncology, biomarker discovery, targeted therapeutics, immunotherapy, precision medicine technologies, cancer genomics, and clinical oncology practices. The Upcoming Oncology Conferences will feature keynote presentations, plenary lectures, oral sessions, poster presentations, panel discussions, and networking opportunities led by internationally recognized experts. Researchers will have the opportunity to showcase their latest studies, exchange knowledge, and establish partnerships that contribute to improving cancer care worldwide. With cancer remaining one of the most significant global health challenges, ICPOC 2026 serves as an important forum for examining emerging scientific evidence and innovative technologies that support personalized treatment approaches. The event welcomes contributions from universities, research institutes, hospitals, biotechnology organizations, pharmaceutical companies, and healthcare agencies. By combining scientific excellence with global accessibility through its hybrid format, Precision Oncology Conference provides a valuable opportunity for professionals to stay informed about cutting-edge discoveries, strengthen professional networks, and contribute to the advancement of oncology research and precision cancer medicine on an international scale. Read more